pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 15·1 min read
save

Nonprofits launch Zillow-style marketplace to match abandoned gene and cell therapies with new developers

May 15, 2026·read at Endpoints ↗Positive

Two nonprofit groups announced the launch of an online marketplace designed to give abandoned cell and gene therapy projects a chance for redevelopment. The platform, unveiled at the American Society of Gene & Cell Therapy meeting in Boston, aims to connect researchers and companies with therapies that have been discontinued.

The initiative is a collaboration between the American Society of Gene & Cell Therapy and the Orphan Therapeutics Accelerator. By cataloguing these dormant assets, the marketplace hopes to streamline the process of finding new partners and funding for further development.

Organizers described the service as a "Zillow-like" listing site, allowing interested parties to browse available therapies and assess their potential. The effort reflects growing interest in rescuing promising but stalled biotech projects.

The launch was announced on Thursday, May 15, 2026, during the ASGCT conference in Boston. Attendees were invited to explore the new tool as a way to reduce waste and accelerate innovation in the gene-therapy field.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live”

read at Endpoints ↗
91 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cell Therapy3Rare Disease2Gene Therapy (AAV)

related stories

  • 4h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • Sep 4STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and moreSTAT
  • Sep 3STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and moreSTAT
  • Sep 3Capricor, Replimune illustrate why FDA must listen to rare disease specialistsBioSpace
  • Aug 31Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concernsBioPharma Dive